Landscapes / Companies
Aragon Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
Drugs
2
in active trials
Trials
6 active
11 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Johnson & Johnson (Janssen) |
Approved | 1 Mar 2027Phase 3 trial completes | ||
| Next date | 1 Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer and 2 more | ||||
| Open drug page | |||||
Cytochrome P450 17A1 inhibitor |
Johnson & Johnson (Janssen) |
Approved | — | ||
| Also tested for | Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021